We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$53.3B
AUM Growth
+$1.63B
(+3.2%)
Cap. Flow
-$179M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
17.17%
Holding
3,102
New
155
Increased
2,027
Reduced
775
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$67.7M |
| 2 |
Corteva
CTVA
|
+$33.4M |
| 3 |
TCF
TCF Financial Corporation Common Stock
TCF
|
+$19.3M |
| 4 |
Spotify
SPOT
|
+$15.3M |
| 5 |
Amcor
AMCR
|
+$15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$62.6M |
| 2 |
Apple
AAPL
|
+$51.5M |
| 3 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$29.7M |
| 4 |
NXP Semiconductors
NXPI
|
+$28.9M |
| 5 |
Microsoft
MSFT
|
+$23.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.25% |
| 2 | Financials | 15.55% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 10.43% |
| 5 | Industrials | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SDRL
2751
DELISTED
Seadrill Limited Common Stock
SDRL
| $222K | ﹤0.01% |
+53,268
| New | +$350K |
|
2752
AXT Inc
AXTI
$4.49B
| $221K | ﹤0.01% |
55,734
+1,182
| +2% | +$5.54K |
|
2753
Ocular Therapeutix
OCUL
$1.84B
| $221K | ﹤0.01% |
50,241
+8,017
| +19% | +$29.7K |
|
|
PZN
2754
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $221K | ﹤0.01% |
25,761
+457
| +2% | +$4.14K |
|
|
BRT
2755
BRT Apartments
BRT
$282M
| $220K | ﹤0.01% |
15,552
+1,181
| +8% | +$16.1K |
|
2756
HF Foods Group
HFFG
$79.7M
| $219K | ﹤0.01% |
+6,301
| New | +$102K |
|
2757
Lands' End
LE
$382M
| $219K | ﹤0.01% |
17,931
+1,585
| +10% | +$23.9K |
|
2758
Ohio Valley Banc Corp
OVBC
$201M
| $219K | ﹤0.01% |
5,677
+21
| +0.4% | +$788 |
|
2759
MVB Financial
MVBF
$399M
| $218K | ﹤0.01% |
12,856
+868
| +7% | +$14.2K |
|
2760
Sportsman's Warehouse
SPWH
$44.9M
| $217K | ﹤0.01% |
57,312
+10,477
| +22% | +$44.6K |
|
2761
Acacia Research
ACTG
$447M
| $216K | ﹤0.01% |
72,908
+2,270
| +3% | +$7.08K |
|
|
RJET
2762
Republic Airways Holdings
RJET
$990M
| $216K | ﹤0.01% |
1,578
+667
| +73% | +$92K |
|
|
ESSA
2763
DELISTED
ESSA Bancorp
ESSA
| $215K | ﹤0.01% |
14,104
+165
| +1% | +$2.54K |
|
2764
EVI Industries
EVI
$180M
| $215K | ﹤0.01% |
+5,619
| New | +$208K |
|
2765
Replimune Group
REPL
$1B
| $215K | ﹤0.01% |
14,668
+3,253
| +28% | +$47K |
|
|
FTSV
2766
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $215K | ﹤0.01% |
20,322
+2,931
| +17% | +$43K |
|
2767
First Northwest Bancorp
FNWB
$107M
| $214K | ﹤0.01% |
13,194
-70
| -0.5% | -$1.13K |
|
2768
Syndax Pharmaceuticals
SNDX
$1.7B
| $214K | ﹤0.01% |
22,991
+3,726
| +19% | +$27.2K |
|
|
ADMS
2769
DELISTED
Adamas Pharmaceuticals
ADMS
| $212K | ﹤0.01% |
34,192
+5,084
| +17% | +$29.2K |
|
2770
Altisource Portfolio Solutions
ASPS
$63.7M
| $210K | ﹤0.01% |
1,333
-463
| -26% | -$82.2K |
|
2771
Cue Biopharma
CUE
$113M
| $210K | ﹤0.01% |
780
+20
| +3% | +$4.97K |
|
|
JAX
2772
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $209K | ﹤0.01% |
18,606
+116
| +0.6% | +$1.25K |
|
|
CASI
2773
DELISTED
CASI Pharmaceuticals
CASI
| $208K | ﹤0.01% |
6,513
+138
| +2% | +$4.41K |
|
2774
Donegal Group Class A
DGICA
$732M
| $208K | ﹤0.01% |
13,618
+890
| +7% | +$12.5K |
|
|
PMBC
2775
DELISTED
Pacific Mercantile Bancorp
PMBC
| $208K | ﹤0.01% |
25,241
+3,329
| +15% | +$26.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2019 Portfolio in Review
As of Q2 2019, RhumbLine Advisers held 3,102 positions worth $53.3B, up 3.2% from $51.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
RhumbLine Advisers's Q2 2019 filing shows 155 new, 2,027 increased, 775 reduced and 131 closed positions. Its largest new stake was Dow Inc: 1,282,896 shares worth $63.3M. The largest sale was DuPont de Nemours, an estimated $62.6M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q2 2019 buy was Dow Inc: 1,282,896 shares worth $63.3M.
- RhumbLine Advisers added most to TCF Financial Corporation Common Stock in Q2 2019, an estimated $19.3M increase.
- RhumbLine Advisers's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $62.6M.
- RhumbLine Advisers fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $29.7M.
- RhumbLine Advisers's ten largest holdings make up 17% of its $53.3B portfolio in Q2 2019.
- RhumbLine Advisers opened 155 new positions and closed 131 in Q2 2019.
- RhumbLine Advisers's portfolio value rose 3.2% quarter-over-quarter to $53.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.